Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYChembio Diagnostics Completes Acquisition of OrangelifePREV STORYFDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease